This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jan;5(1):14-5.

doi: 10.1038/ncpcardio1034. Epub 2007 Oct 16.

How can the bleeding risk associated with warfarin therapy be reduced?

Freek W A Verheugt¹

Affiliations

PMID: 17940514
DOI: 10.1038/ncpcardio1034

Comment

How can the bleeding risk associated with warfarin therapy be reduced?

Freek W A Verheugt. Nat Clin Pract Cardiovasc Med. 2008 Jan.

. 2008 Jan;5(1):14-5.

doi: 10.1038/ncpcardio1034. Epub 2007 Oct 16.

Author

Freek W A Verheugt¹

Affiliation

¹ Department of Cardiology, University Medical Center Nijmegen, Nijmegen, The Netherlands. f.verheugt@cardio.umcn.nl

PMID: 17940514
DOI: 10.1038/ncpcardio1034

No abstract available

PubMed Disclaimer

Comment on

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.
Wysowski DK, Nourjah P, Swartz L. Wysowski DK, et al. Arch Intern Med. 2007 Jul 9;167(13):1414-9. doi: 10.1001/archinte.167.13.1414. Arch Intern Med. 2007. PMID: 17620536

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.